| | 864070-44-0 Basic information More.. |
| Product Name: | Empagliflozin | | Synonyms: | EMPAGLIFLBZIN;EMpagliflozin;BI-10773;EMpagliflozin/ BI-10773;D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]M ethyl]phenyl]-, (1S)-;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol Empagliflozin BI 10773;Empagliflozin Impurity A;(1S)-1,5-Anhydro-1-C-{4-chloro-3-[(4-{[(3S)-oxolan-3-yl]oxy}phenyl)methyl]phenyl}-D-glucitol | | CAS: | 864070-44-0 | | MF: | C23H27ClO7 | | MW: | 450.91 | | EINECS: | 620-176-8 | | Mol File: | 864070-44-0.mol |  |
Use
Empagliflozin(trade name Jardiance) is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and causes sugar in the blood to be excreted by the kidneys and eliminated in urine. On August 1, 2014, the Food and Drug Administration (FDA) officially approved the drug for the treatment of type 2 diabetes, to improve and control blood glucose of adults.
- Empagliflozin
-
- US $0.00 / KG
- 2025-06-26
- CAS:864070-44-0
- Min. Order: 1KG
- Purity: 99.5%min
- Supply Ability: 100KGS
- Empagliflozin
-
- 2025-06-26
- CAS:864070-44-0
- Min. Order:
- Purity: 0.99
- Supply Ability:
- Empagliflozin
-
- US $39.00-72.00 / mg
- 2025-06-23
- CAS:864070-44-0
- Min. Order:
- Purity: 99.89%
- Supply Ability: 10g
|
|
864070-44-0
Recommend Suppliers |
|